CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to identify new biomarkers for lung squamous cell cancer using non-invasive exhaled breath condensate sampling. By analyzing microbial and host genomic signatures through advanced sequencing techniques, it seeks to differentiate between lung cancer and non-malignant nodules, potentially guiding target…
Lung cancer is a leading cause of cancer related mortality, claiming an estimated 1.8 million lives in 2020.
In the EU, lung cancer accounts for 12% of all new cancer diagnoses and 20% of all cancer deaths, Although helpful in identifying early-stage lung cancer, screening programs frequently lead to false-positives and overdiagnosis.
This is exacerbated by a lack of clinically useful biomarkers to accurately differentiate between lung cancer and indeterminate nodules found in the lung.
Recent s…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
